The series on tumor immune microenvironment in cancer progression and cancer therapy includes articles analyzing the role of microenvironmental acidity and TEs, the immune cells such as MDSCs, and genetic factors such as miRNAs. The TME has profound impacts on cancer progression and remodeling of the TME has become a strategy to facilitate cancer therapy.
Editorial on Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy
Preface to the series on tumor immune microenvironment in cancer progression and cancer therapy
Review Article on Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy
Role of microenvironmental acidity and tumor exosomes in cancer immunomodulation
Antitumor effects of targeting myeloid-derived suppressive cells
MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers
Disclosure:
The focused issue “Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Jia Wei is serving as the unpaid Guest Editor for the focused issue.